- $10.73bn
- $10.42bn
- $738.26m
Repligen Corp expected to post earnings of 30 cents a share - Earnings Preview
Brief: Repligen Appoints Maggie A. Pax To Board Of Directors
U.S. STOCKS ON THE MOVE-Nvidia, Global Payments
U.S. STOCKS ON THE MOVE-Toll Brothers, Natgas firms, Eton Pharmaceuticals
Repligen Corp reports results for the quarter ended in December - Earnings Summary
Repligen falls on downbeat annual results forecast
Brief: Repligen Q4 Adjusted EPS USD 0.33 Vs. IBES Estimate USD 0.33
Repligen Corp expected to post earnings of 33 cents a share - Earnings Preview
Brief: Repligen Announces Private Convertible Transaction Of $600 Mln Principal Amount Of 1% Convertible Senior Notes
Repligen Corp reports results for the quarter ended in September - Earnings Summary
Brief: Repligen Narrows Full Year Revenue Guidance To Range Of $635-$645 Million
Brief: Repligen Q3 Adjusted EPS USD 0.23 Vs. IBES Estimate USD 0.17
Repligen Corp expected to post earnings of 17 cents a share - Earnings Preview
Brief: Repligen Corp Says Proposed Deal With Metenova For Purchase Price Of About $170 Million (About $162 Mln Cash, About $8 Mln Equity)
Brief: Repligen Appoints Jason Garland As Chief Financial Officer
U.S. RESEARCH ROUNDUP-Intuit, Pioneer Natural Resources, Salesforce
Repligen Corp reports results for the quarter ended in June - Earnings Summary
Brief: Repligen Q2 Adjusted EPS USD 0.53 Vs. IBES Estimate USD 0.48
Repligen Corp expected to post earnings of 48 cents a share - Earnings Preview